← SynDRA
ISUZINAXIB
SynDRA canonical compound SYN0040202 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | NOX1 | NOX4 |
| Mechanism of action | nadph oxidase inhibitor |
| Indication | diabetic nephropathy |
| Disease area | nephrology |
All known targets
Mechanisms of action (all sources)
Cross-references
Look up ISUZINAXIB in the interactive SynDRA portal →